News


Tessenderlo Group has the intention to sell its pharmaceutical ingredients activities to International Chemical Investors Group

09. October 2012

Brussels / Luxembourg – Tessenderlo Group (NYSE Euronext: TESB) announced today that it has the intention to sell its pharmaceutical ingredients activities, Farchemia and Calaire Chimie, to International Chemical Investors Group...more


ICIG acquires Roche’s pharmaceutical manufacturing facility in Boulder, Colorado

04. August 2011

Boulder, CO – The Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and International Chemical Investors Group (ICIG) announced today that they have entered into an agreement for ICIG to acquire Roche Colorado Corporation, which includes...more


International Chemical Investors Group Announces Agreement to Acquire Pharmaceutical Intermediates Business From Genzyme

03. February 2011

Luxembourg – International Chemical Investors Group (ICIG) announced that it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation....more


WeylChem launches WeylChem International

18. January 2011

The Fine Chemicals Platform of International Chemicals Investors (ICIG), WeylChem Group, offers Custom Manufacturing services as well as Advanced Intermediates & Reagents. WeylChem’s manufacturing sites are located in Germany...more


Bristol-Myers Squibb announces the activation of Art. 47 for the Latina Plant

29. March 2010

Latina, March 29, 2010. Bristol-Myers Squibb announced today that will inform the unions that it is commencing the procedures under Art. 47 law no. 428/1990 in connection with the transfer of its manufacturing plant based in...more


AstraZeneca sells the Caponago site to International Chemical Investors Group

01. July 2009

AstraZeneca Italy, a subsidiary of AstraZeneca PLC, has sold the company's site in Caponago (Milano) to Corden Pharma SpA, belonging to the International Chemical Group, ICIG. The agreement foresees, amongst the terms &...more


International Chemical Investors Announce Acquisition of Miteni, Italy

02. February 2009

LUXEMBOURG, FRANKFURT / PR Newswire-FirstCall - International Chemical Investors Group (ICIG) announced today that it signed a definitive share purchase and sale agreement to acquire Miteni S.p.A. (Miteni), Italy from Mitsubishi...more


Albemarle Completes the Sale of its Port de Bouc, France Facility to International Chemical Investors Group

02. January 2009

BATON ROUGE, La. and FRANKFURT, Germany, Jan. 2 /PRNewswire-FirstCall - Albemarle Corporation (NYSE: ALB) and International Chemical Investors Group ("ICIG") announced today that Albemarle Chemicals SAS, a wholly owned...more


Albemarle Announces Initiation of Consultation Process with Works Council At Its Facility in Port de Bouc, France

23. October 2008

BATON ROUGE, La. and FRANKFURT, Germany, Oct. 23 /PRNewswire-FirstCall - Albemarle Corporation (NYSE: ALB) and International Chemical Investors Group ("ICIG") announced today that Albemarle Chemicals SAS, a wholly owned...more


Corden Pharma GmbH heißt die Zukunft für das AstraZeneca Werk in Plankstadt

01. February 2008

Plankstadt, 01.02.2008 - Der Verkauf des AstraZeneca-Werkes Plankstadt ist abgeschlossen. Ab heute gehört das Werk der International Chemical Investors Group (ICIG), Frankfurt/Main, und heißt ab sofort Corden Pharma GmbH. Als...more

Displaying 21 to 30 of 40